Cambodia vs Senegal: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cambodia
0.4%
in 2024
Senegal
0.4%
in 2024
Cambodia rank
59th
Senegal rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cambodia
- Senegal
How they compare
Cambodia currently reports 0.4% against 0.4% in Senegal, a difference of 0.0%.
Across all 10 years both countries report, Senegal has been ahead every year.
Cambodia ranks 59th and Senegal ranks 59th of 215 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.8% | 0.4% | Senegal |
| 2020s | 0.4% | 0.5% | 0.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cambodia or Senegal?
- Cambodia, at 0.4% against 0.4% in Senegal as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cambodia and Senegal?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Senegal rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cambodia ranks 59th and Senegal ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.